Elacestrant – July 2026

  • Tablet 86 mg (as dihydrochloride)
  • Tablet 345 mg (as dihydrochloride)

  • Brand names:
    • Orserdu®
  • Pharmaceutical Company:
    • A.MENARINI AUSTRALIA PTY LIMITED
  • Condition/Indication: Breast cancer
  • Meeting Date: July 2026

Last updated
13 November 2026